Leishmaniasis y nodulosis reumatoide en paciente con infección por el virus de la inmunodeficiencia humana

García-Río, Irene; Daudén, E.; Ballestero-Díez, M.; Fraga, Javier; García‐Diez, Amaro

doi:10.1016/j.ad.2009.01.001

Cited by 5 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Mucocutaneous lesions caused by L. infantum have also been described in HIV-positive patients [42]. Leishmania parasites have been detected in biopsies obtained from VL/HIV-coinfected patients that were performed to study other skin lesions, such as rheumatoid nodulosis and Kaposi's sarcoma [27], [43]. In some cases, the detection of Leishmania in cutaneous lesions led to the diagnosis of VL; however, the presence of the parasite in skin diseases in which it has no known etiological role may represent passive presence due to widespread dissemination in patients with compromised immune systems [37], [44].…”

Section: Clinical Manifestations Of Visceral Leishmaniasis In Hiv-coimentioning

confidence: 99%

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region

Monge‐Maíllo

Norman²,

Cruz³

et al. 2014

PLoS Negl Trop Dis

109

View full text Add to dashboard Cite

Visceral leishmaniasis is hypoendemic in Mediterranean countries, where it is caused by the flagellate protozoan Leishmania infantum. VL cases in this area account for 5%–6% of the global burden. Cases of Leishmania/HIV coinfection have been reported in the Mediterranean region, mainly in France, Italy, Portugal, and Spain. Since highly active antiretroviral therapy was introduced in 1997, a marked decrease in the number of coinfected cases in this region has been reported. The development of new diagnostic methods to accurately identify level of parasitemia and the risk of relapse is one of the main challenges in improving the treatment of coinfected patients. Clinical trials in the Mediterranean region are needed to determine the most adequate therapeutic options for Leishmania/HIV patients as well as the indications and regimes for secondary prophylaxis. This article reviews the epidemiological, diagnostic, clinical, and therapeutic aspects of Leishmania/HIV coinfection in the Mediterranean region.

show abstract

Section: Clinical Manifestations Of Visceral Leishmaniasis In Hiv-coimentioning

confidence: 99%

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region

Monge‐Maíllo

Norman²,

Cruz³

et al. 2014

PLoS Negl Trop Dis

109

View full text Add to dashboard Cite

show abstract

“…A high incidence, especially in Spain, of Leishmania/HIV coinfection suggests that HIV infection might pose a risk for leishmaniasis and vice versa [ 163 ]. It has been shown that detectable peripheral blood parasitemia is more frequent in PLWH than in not-HIV-infected people [ 164 ]. Typical features of VL are fever, weight loss, hepatosplenomegaly and pancytopenia.…”

Section: Leishmaniasismentioning

confidence: 99%

HIV and Mediterranean Zoonoses: A Review of the Literature

Russotto

Micali

Pellicanò

et al. 2022

Infectious Disease Reports

View full text Add to dashboard Cite

A zoonosis is an infectious disease that has jumped from a non-human animal to humans. Some zoonoses are very common in the Mediterranean area and endemic in specific regions, so they represent an important problem for public health. Human Immunodeficiency Virus (HIV) is a virus that has originated as a zoonosis and is now diffused globally, with the most significant numbers of infected people among the infectious diseases. Since the introduction of antiretroviral therapy (ART), the history for people living with HIV (PLWH) has changed drastically, and many diseases are now no different in epidemiology and prognosis as they are in not-HIV-infected people. Still, the underlying inflammatory state that is correlated with HIV and other alterations related to the infection itself can be a risk factor when infected with other bacteria, parasites or viruses. We reviewed the literature for infection by the most common Mediterranean zoonoses, such as Campylobacter, Salmonella, Brucella, Rickettsia, Borrelia, Listeria and Echinococcus, and a possible correlation with HIV. We included Monkeypox, since the outbreak of cases is becoming a concern lately. We found that HIV may be related with alterations of the microbiome, as for campylobacteriosis, and that there are some zoonoses with a significant prevalence in PLWH, as for salmonellosis.

show abstract

HIVand the Skin

Bunker

Piguet

2016

Rook's Textbook of Dermatology, Ninth Edition

View full text Add to dashboard Cite

Acquired immune deficiency syndrome (AIDS) has been recognized, and human immunodeficiency virus (HIV) identified as the causative agent, for over 30 years. HIV infection is a significant health problem globally. Earlier diagnosis and initiation of antiretroviral treatment (ART) prevents death, serious sequelae and onward transmission. Mucocutaneous involvement may allow diagnosis at seroconversion or later in the course of the disease and dermatologists should have a very low threshold for considering the diagnosis and offering HIV testing routinely in many common presenting clinical scenarios. Combined ART has revolutionized treatment, and long‐term survival is the norm. However, there are significant dermatological consequences of HIV treatment including drug reactions/complications and immune reconstitution‐associated disease. Primary skin malignancies are the most frequent non‐AIDS‐defining cancers and oral, anal and genital (e.g. penile) cancers are significantly increased in the HIV‐treated population.

show abstract

Leishmaniasis y nodulosis reumatoide en paciente con infección por el virus de la inmunodeficiencia humana

Cited by 5 publications

References 14 publications

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region

Visceral Leishmaniasis and HIV Coinfection in the Mediterranean Region

HIV and Mediterranean Zoonoses: A Review of the Literature

HIVand the Skin

Contact Info

Product

Resources

About